Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹489 Cr₹90 Cr₹94 Cr₹80 Cr₹81 Cr

What is the latest Total Non-Current Liabilities ratio of GLAND PHARMA ?

The latest Total Non-Current Liabilities ratio of GLAND PHARMA is ₹489 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹489 Cr
Mar2023₹90 Cr
Mar2022₹94 Cr
Mar2021₹80 Cr
Mar2020₹81 Cr

How is Total Non-Current Liabilities of GLAND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹489 Cr
444.83
Mar2023 ₹90 Cr
-4.57
Mar2022 ₹94 Cr
17.01
Mar2021 ₹80 Cr
-0.58
Mar2020 ₹81 Cr -

Compare Total Non-Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,022.3 Cr -3.4% -11.2% 2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹453,486.0 Cr -0.6% 1.3% 65.7% Stock Analytics
DIVIS LABORATORIES ₹161,321.0 Cr -1.1% 11.4% 64% Stock Analytics
CIPLA ₹125,852.0 Cr -2.3% -6.8% 33.8% Stock Analytics
DR REDDYS LABORATORIES ₹111,799.0 Cr 1.5% 1% 22.9% Stock Analytics
ZYDUS LIFESCIENCES ₹102,726.0 Cr -4.2% -8.1% 72.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-3.4%

-11.2%

2.7%

SENSEX

-0.7%

-2.4%

22%


You may also like the below Video Courses